期刊文献+

三维适形大分割放疗联合TP方案治疗老年局部晚期非小细胞肺癌的临床观察 被引量:9

Three-dimensional conformal Hypofractionated Radiotherapy combined with TP Regimen for Treatment of Senile Locally Advanced Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的 观察三维适形大分割放疗联合TP 方案治疗老年局部晚期NSCLC 的临床疗效和毒副反应.方法 46 例NSCLC 患者采用三维适形大分割放疗,每次4 ~ 8Gy,3f/W,总剂量40 ~ 64Gy.放疗结束后1 ~ 2 周给予TP 方案化疗,具体为:多西他赛75mg/m2 静滴,d1;卡铂300mg/m2 静滴,d1,3 ~ 4 周为1 周期,共2 ~ 4 周期.化疗结束后1 个月评价疗效.结果 46 例患者均完成治疗,总有效率为89.1%,1、2、3 年生存率分别为82.6%、47.8% 和26.1%.急性放射性肺炎发生率为17.4%,急性放射性食管炎发生率8.7%,白细胞减少发生率为73.9%,恶心呕吐发生率为21.7%,均为1~2 级.结论 三维适形大分割放疗联合TP 方案治疗老年局部晚期NSCLC 患者的疗效可靠,毒副反应轻,值得临床进一步研究. Objective To evaluate the clinical efficacy and toxicity of three-dimension conformal radiotherapy sequential TP regimen for treatment of elderly patients with locally advanced non-smaU cell lung cancer. Methods 46 case of elderly patients with locally advanced NSCLC were treated by three-dimension conformal hypofractionated high dose radiotherapy: total dose from 40 to 64Gy,6 to 8Gy for each fi'action,3f/W. TP regimen ( docetaxel 75 mg/m2, dl and carboplatin 300 mg/m2, dl, 21-28 days was a cycle) followed 1-2 weeks after 3DCRT.Each patient should complete no less than two cycles' chemotherapy.The response and toxicity were evaluate and survival rats was followed up. Results The toal response rate was 89.1%.The 1-,2- and3- year survival rats was 82.6%,47.8%,and 26.1%.The main toxicities were local radiation pneumonia (17.4%) ,radiation esophagitis (8.7%) ,leucopenia (73.9%) ,and nausea/vomiting (21.7%) ,mainly grade 1-2. Conclusion The three dimensional conformal hypofractionated high dose radiotherapy sequential TP regimen for elderly patients with locally advanced NSCLC is effective. The toxicities are mild, It is worthy of further study.
机构地区 解放军第
出处 《中国医药指南》 2012年第23期74-75,共2页 Guide of China Medicine
关键词 非小细胞肺癌 三维适形放疗 大分割放疗 化疗 Non-small cell lung cancer Three dimensional conformal radiotherapy Hypofractionated radiotherapy Chemotherapy
  • 相关文献

参考文献4

二级参考文献22

  • 1杨秋敏.长春瑞滨联合放疗对老年晚期非小细胞肺癌患者生活质量的影响[J].中国临床康复,2004,8(26):5512-5513. 被引量:2
  • 2江启安,赵美红,郎丰平.三维适形低分割放射治疗老年非小细胞肺癌疗效观察[J].中华放射肿瘤学杂志,2004,13(4):289-290. 被引量:27
  • 3欧广飞,王绿化,张红星,陈东福,肖泽芬,冯勤付,周宗玫,吕纪马,梁军,汪楣,殷蔚伯.289例局部晚期非小细胞肺癌放疗和放化综合治疗结果[J].中华放射肿瘤学杂志,2007,16(2):86-90. 被引量:30
  • 4Jemal A,Murray T,Samuels A,et al.Cancer statistics,2003.CA Cancer J Clin,2003,53:208-226.
  • 5National Center for Health Statistics.United States Life Tables,2000.Available from:http://www.cdc.gov/nchs/products/pubs/pubd/nvsr/51/51-03.htm.
  • 6Balducci L,Extermann M.Management of cancer in the older person:a practical approach.Oncologist,2000,5:224-237.
  • 7Hurria A,Kris MG.Management of Lung Cancer in Older Adults.CA Cancer J Clin,2003,53:325-341.
  • 8Jett JR, Schild SE, Keith RL, et al. Treatment of on-small cell lung cancer,state Ⅲb:ACCP evidence-based clinic, 1 practice guidelines (2nd edition)[J]. Chest, 2007,132(3) :2665-27651.
  • 9Clement D, Miron L, Marinca M, et al. Age-ralated prognostic factors and treatment results for advanced non-small cell lung cancer (NSCLC)[J]. Roy Med Chit Soc Med Nat Iasi, 2007,111(4): 856-863.
  • 10Gridelli C, Langer C, Maione P, et al. Lung cancer in the elderly [J]. J Clin Oncol, 2007,25(14) :1898-1907.

共引文献30

同被引文献60

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1469
  • 2徐继庆,张波,胡广,朱晓峰,邹志田,张福亭.NP化疗加手术对III期非小细胞肺癌(NSCLC))疗效分析[J].黑龙江医药科学,2006,29(2):46-47. 被引量:1
  • 3唐求,杨坤禹,王鹏,胡绍,胡从良.大分割三维适形放疗联合低剂量密集式化疗治疗III期非小细胞肺癌72例临床分析[J].肿瘤防治研究,2006,33(6):453-454. 被引量:3
  • 4Chu TQ,Ding H,Garfield DH,et al.Can determination of circulating endothelial cells and serum caspase-cleaved CK18 predict for response and survival in patients with advanced non-small-cell lung cancer receiving endostatin and paclitaxel-carboplatin chemotherapy? a retrospective study[J].J Thorac Oncol,2012,7(12):1781-1789.
  • 5Mountzios G,Emmanouilidis C,Vardakis N,et al.Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment:a phase Ⅱ multicenter study of the Hellenic Oncology Research Group[J].Lung Cancer,2012,77(1):146-150.
  • 6Tombolini V, Bonanni A, Donato V, et al. Radiotherapy alone in elderly patients with medically inoperable stage m A and ]1I B non-small cell lung cancer [ J 1. Anticancer Res, 2000 ;20 ( 6 C ) :4829 -33.
  • 7L. Repetto,A. Venturino,L. Fratino,D. Serraino,G. Troisi,W. Gianni,M. Pietropaolo.??Geriatric oncology(J)European Journal of Cancer . 2003 (7)
  • 8Detterbeck Frank C,Boffa Daniel J,Tanoue Lynn T.The new lung cancer staging system. Chest . 2009
  • 9Zhongxing X. Liao,Ritsuko R. Komaki,Howard D. Thames,Helen H. Liu,Susan L. Tucker,Radhe Mohan,Mary K. Martel,Xiong Wei,Kunyu Yang,Edward S. Kim,George Blumenschein,Waun Ki Hong,James D. Cox.??Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy(J)International Journal of Radiation Oncology, Biology, Physics . 2010 (3)
  • 10Owonikoko Taofeek K,Ragin Camille C,Belani Chandra P,Oton Ana B,Gooding William E,Taioli Emanuela,Ramalingam Suresh S.Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2007

引证文献9

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部